| Literature DB >> 35621961 |
Shuting Qiu1,2, Shipeng Zhou1,2, Yue Tan1,2, Jiayao Feng1,2, Yan Bai3, Jincan He3, Hua Cao4, Qishi Che5, Jiao Guo2, Zhengquan Su1,2.
Abstract
Marine crustacean waste has not been fully utilized and is a rich source of chitin. Enzymatic degradation has attracted the wide attention of researchers due to its unique biocatalytic ability to protect the environment. Chitosan (CTS) and its derivative chitosan oligosaccharides (COSs) with various biological activities can be obtained by the enzymatic degradation of chitin. Many studies have shown that chitosan and its derivatives, chitosan oligosaccharides (COSs), have beneficial properties, including lipid-lowering, anti-inflammatory and antitumor activities, and have important application value in the medical treatment field, the food industry and agriculture. In this review, we describe the classification, biochemical characteristics and catalytic mechanisms of the major degrading enzymes: chitinases, chitin deacetylases (CDAs) and chitosanases. We also introduced the technology for enzymatic design and modification and proposed the current problems and development trends of enzymatic degradation of chitin polysaccharides. The discussion on the characteristics and catalytic mechanism of chitosan-degrading enzymes will help to develop new types of hydrolases by various biotechnology methods and promote their application in chitosan.Entities:
Keywords: chitin deacetylase; chitinase; chitosan oligomers; chitosanase; enzymatic modification
Mesh:
Substances:
Year: 2022 PMID: 35621961 PMCID: PMC9146327 DOI: 10.3390/md20050310
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Process of enzymatic degradation of chitosan.
Recent applications of chitosan.
| Name | Physical Representation | Function | Mechanism of Action | Refs. |
|---|---|---|---|---|
| CTS | DD: 92.78% | Antifungal applications against human pathogens. | The increased cationic charges on the nanoparticle surfaces that may contribute to enhanced interaction with the negatively charged cell membrane and its disruption. | [ |
| CTS | S@CS NPs were prepared by mixing the chitosan (CS) and spike protein (S), (CS: 5 μg, S: 5 μg) | Favorable mucosal vaccine adjuvant with aerosol inhalation | The CS-mediated inhalable nanovaccine stimulated balanced immunity between humoral and cellular immunity without systemic toxicity | [ |
| CTS | DD: 77.6–82.5% | Used as the polymer basis of the film | The film releases the drug along a saturation curve, initially faster for the anionic drug and slower for the cationic drug. | [ |
| CTS | MW: 50–190 kDa | As an injectable delivery system | Promoting the change of surface charge from negative to positive and to enhance their interaction with cells | [ |
| CTS | NA | Drug delivery system | Act as a barrier material to delay the diffusion and degradation of PLGA microspheres for longer duration of action. | [ |
| OCS | Mn ≤ 3000 Da | Bone regenerative properties are prepared using sodium tripolyphosphate (TPP) as a crosslinker | Promote osteogenesis with its anti-inflammatory and antioxidant abilities | [ |
| CS | DD ≥ 95% | High-performance protein-based multifunctional adhesives | When CS molecules and the fractured BN came into close contact, they reacted with each other and formed a high interfacial binding energy | [ |
| CS | MW: 50–90 kDa | As nanofillers | Significant improvement in surface hydrophobicity, moisture and light barrier potential, mechanical strength and antioxidant properties of the composite films | [ |
| CS | MW: 20 kDa | The natural polymeric flocculants | Restrained the release of organic substrates from solid phase to liquid phase, from macromolecules to micromolecules and finally to methane | [ |
| CS | DD: 90% | Permeation enhancer | Carries a positive charge and can increase skin permeability by opening the tight junctions of the stratum corneum | [ |
NA: Not available; CTS: Chitosan; CS: Chitosan; OCS: Chitosan; MW: Weight-average Molecular Weight; DD: Degree of Deacetylation; Mn: Number-average Molecular Weight.
Recent applications of COS.
| Name | Physical Representation | Function | Mechanism of Action | Refs. |
|---|---|---|---|---|
| SCOS | DP: 3–7 | Enhance the anti-influenza A virus (IAV) activity of COS | Blocked IAV entry through interfering with both virus adsorption and membrane fusion processes | [ |
| COS | DP: 3–7 | Non-toxic biological antibacterial agent | Inactivated Escherichia coli through the sublethal injury process. For Staphylococcus aureus, some cells were induced into VBNC state by COS | [ |
| EVs-COS | NA | As a scaffold to promote the effects of AMSC-derived | EVs-COS could facilitate cartilage injury repair and have better protective effects on OA by promoting the viability and migration of chondrocytes, suppressing cell apoptosis and regulating COL1A1, COL2A1, OCN, OPN, RUNX2, c-Myc, p53, Bcl2 and the Akt/PI3K pathway. | [ |
| COST/COSM | COST (MW ≤ 1000 Da) | Ameliorate APAP-induced liver oxidative damage | Inhibit toxic APAP metabolism, inhibit oxidative damage and the apoptosis pathway, increase activation of the liver antioxidant pathway | [ |
| COS | DD: 95.6% | Antifungal activity | Inhibitory to food spoilage fungi via damaging cell walls and membranes and disrupting normal cellular metabolism. | [ |
| COS | MW < 1kDa | Alleviate the symptoms of constipation by beneficially regulating the levels of endogenous metabolites. | Most significantly changed metabolic pathways in plasma of constipated mice induced by loperamide, including those correlated with the metabolisms of sphingolipid, glycerophospholipid, tryptophan, bile acids, unsaturated fatty acids and amino acids. | [ |
| COS | DD: 90% | A preventive and therapeutic effect in mice with DSS-induced chronic UC | Attenuating inflammatory response, ameliorating colonic apoptosis, promoting the proliferation of crypt epithelial cells and modulating gut microbiota | [ |
| COS | MW < 1500 Da | Ameliorate metabolic syndrome | Improved their function related to intestinal barrier and glucose transport. | [ |
| COS | purity > 95% | Markedly inhibit osteosarcoma cell viability, metastasis, apoptosis and autophagy in vitro and in vivo. | COS-induced autophagy was initiated by the activation of the p53/mTOR pathway. | [ |
| COS | NA | Potent immunomodulatory and hepatoprotective effects | COS inhibited the JAK2/STAT1 pathways on M1 macrophages and the JAK1/STAT6 pathways on M2 macrophages in KCs. | [ |
| COS | MW: 1100, 2500, 3600 Da | Enhanced antitumor immunity | Inhibited the expression of PD-L1 through the activation of AMPK and the suppression of STAT1 signaling | [ |
| COS | MW < 1 kDa | Attenuate experimental severe acute pancreatitis | Inhibiting oxidative stress and modulating intestinal homeostasis | [ |
NA: Not available; SCOS: Sulfated Chitooligosaccharide; EVs-COS: Extracellular Vesicles binding with Chitosan Oligosaccharides; COST/COSM: Chitosan Oligosaccharides; COS: Chitosan Oligosaccharides; MW: Weight-average Molecular Weight; DD: Degree of Deacetylation; DP: Degrees of Polymerization.
Sources and biochemical properties of chitinase.
| Organism | Expression Host | Molecular Mass (kDa) | Optimal Temperature (°C) | Optimal pH | Activity (U/mg) | Inhibitor | Activator | Refs. |
|---|---|---|---|---|---|---|---|---|
| 47 | 55 | 5 | 66.2 | Fe3+, Cu2+, Na+, EDTA, SDS | Mn2+, Ba2+, Na+ | [ | ||
| 35.5 | 40 | 6 | 26.2 | Ca2+, WRK, urea, Hg2+ | Cu2+ | [ | ||
|
|
| 42 | 37 | 4.5 | NA | NA | NA | [ |
| NA | 42 | 60 | 6 | 14.2 U/mL | NA | NA | [ | |
| 26.99 | 35 | 8 | NA | NA | NA | [ | ||
| Marine bacteria DW2 |
| 39.5 | 30 | 5 | 7.3 | Cr3+, Ni2+, Fe3+, Mn2+, Cu2+, EDTA, SDS, Hg2+, Ag+ | Ca2+, Zn2+, Mg2+, β-mercaptoethanol | [ |
| soil of a mangrove tidal flat | 43 | 45 | NA | 0.63 | SDS, EDTA, Fe3+, Cu2+, Mn2+, Co2+, Ag+, Hg2+ | K+, Na+ | [ | |
| actinobacterium | NA | 52 | 40 | 8 | 680.0 IU | Hg2+, Pb2+ | Mn2+, Cu2+, Mg2+ | [ |
| C.shinanensis | 58.87 | 50 | 7 | NA | NA | NA | [ | |
| NA | 55 | 4.5 | 12 | NA | NA | [ | ||
|
|
| 52 | 40 | 6 | NA | NA | NA | [ |
|
| NA | 18 | 50 | 6.5 | NA | Cu2+, Hg2+, EDTA | β-ME | [ |
| Chitinolyticbacter meiyuanensis SYBC-H1 | 110 | 50 | 6 | 4.1 | Cu2+, Ni2+, Fe3+ | Fe2+, Mg2+, Ba2+, Na+ | [ | |
| 3ZYB medium | 50 | 60 | 7 | 480.2 | NA | Ca2+, Mn2+, Mg2+, Na+, Fe2+, Cu2+, EDTA and β-mercaptoethanol | [ | |
|
| NA | 52 | 40 | 6 | NA | NA | NA | [ |
NA: Not available; EDTA: Ethylenediaminetetraaceticacid; SDS: Sodium Dodecyl Sulfate; WRK: Woodward’s reagent K.
Figure 2Three-dimensional structures of chitinase: (A) Chitinase Chi23 (PDB ID: 6K7Z) of family GH18 from Pseudoalteromonas aurantia; (B) Chitinase ChtII (PDB ID: 5Y29) of family GH18 from the insect pest Ostrinia furnacalis; (C) Chitinase PrChiA-cat (PDB ID: 4RL3) of family GH18 from the fern, Pteris ryukyuensis; (D) Chitinase ChiA1 (PDB ID: 2XVP) of family GH18 from Aspergillus fumigatus; (E) Chitinase ChitA (PDB ID: 4MCK) of family GH19 from Zea mays. β-Strands are shown in cyan-blue and α-helices in magenta. Loops and other secondary structures are in ginger.
Figure 3(A) The substrate assisted mechanism of chitinase. Acid/base amino acid group are in red ball. (B) Single displacement catalytic mechanism of chitinase. Base amino acid group is in bright purple ball. Acid amino acid group is in dark purple ball.
Sources and biochemical properties of CDA.
| Organism | Expression Host | Molecular Mass (kDa) | Optimal Temperature (°C) | Optimal pH | Activity (U/mg) | Inhibitor | Activator | Refs. |
|---|---|---|---|---|---|---|---|---|
| NA | 53 | 50 | 9 | NA | NA | Cu2+, Co2+ | [ | |
|
| NA | 75 | 37 | 6 | NA | Cu2+ | Mn2+, Mg2+ | [ |
|
| 24.2 | 50 | 8 | 4.17 | NA | NA | [ | |
|
| 43 | 28 | 7.4 | NA | NA | NA | [ | |
|
| NA | NA | 40 | 7 | NA | Mg2+, Cu2+, Zn2+ | Ca2+, K+ | [ |
|
| NA | NA | 50 | 8 | NA | NA | NA | [ |
| NA | 30 | 30 | 8 | 50 | Co2+, Ba 2+, EDTA | Sr2+, Mg2+, Na+ | [ | |
|
| NA | 27 | 50 | 9 | 693.92 ± 0.30 | EDTA, Cu2+, Zn2+, Al3+, Fe2+, Ca2+ | Co2+, Mg2+ | [ |
|
| NA | 35 kDa and 170 kDa | 28 | 6 | 0.018 | NA | NA | [ |
| NA | NA | 55 | 6.5 | NA | acetate, EDTA | Co2+, Ca2+, Mg2+ | [ | |
|
| NA | 28 | 50 | 8 | NA | NA | Mn2+, Zn2+ | [ |
| NA | 26 | 30 | 8 | 137.54 | Co2+, Cd2+, EDTA | K+,Sr+ | [ |
NA: Not available; EDTA: Ethylenediaminetetraaceticacid.
Figure 4Three-dimensional structures of CDA: (A) ClCDA (PDB ID: 2IW0) from the fungal pathogen Colletotrichum lindemuthianum; (B) ArCDA (PDB ID: 5LFZ) from a marine Arthrobacter species; (C) AnCDA (PDB ID: 2Y8U) from Aspergillus Nidulans Fgsc A4; (D) VcCDA (PDB ID: 4NY2) from the Vibrio cholerae; (E) VpCDA (PDB ID: 3WX7) from Vibrio parahaemolyticus. β-Strands are shown in cyan-blue and α-helices in magenta. Loops and other secondary structures are in ginger.
Figure 5The catalytic reaction of CDA.
Sources and biochemical properties of chitosanases.
| Organism | Expression Host | Molecular Mass (kDa) | Optimal Temperature (°C) | Optimal pH | Activity (U/mg) | Inhibitor | Activator | Refs. |
|---|---|---|---|---|---|---|---|---|
| NA | 47 | 45 | 4 | NA | NA | NA | [ | |
|
| 35 | 30 | 7 | 89.2 | EDTA, Ba2+, Mg2+, Ca2+, Ni2+, Co2+ | Mn2+, Zn2+, Cu2+ | [ | |
| blue crab viscera | NA | NA | 60 | 4 | 100 U/g | Hg2+, Cu2+ | Al2+, Ba2+, Ca2+, K+, Mg2+, Na+, Zn2+, Mn2+ | [ |
|
| 29.6 | 50 | 8 | Mg2+, Fe3+, Zn2+, SDS | Mn2+, Cu2+, Ba2+ | [ | ||
| 28 | 55 | 6 | 34 | Fe2+, Zn2+, Ge2+, Ni2+, Cu2+ | Ca2+, Mn2+, Mg2+ | [ | ||
| Chromobacterium violaceum |
| 38 | 50 | 6.0, 11 | 10,000 | Pb2+, Fe3+, Hg2+, Ni2+, Ag+, Rb+, Fe2+, SDS | Ca2+, Co2+, Cu2+, Sr2+, Mn2+ | [ |
|
|
| 29 | 55 | 6.5 | 2380.5 | NA | NA | [ |
| pabuli |
| 56 | 45 | 6 | NA | NA | NA | [ |
|
| 29 | 40 | 5.6 | NA | NA | NA | [ | |
| 27.1 | 60 | 5.8 | 412.6 | Cu2+, Ni2+, Co2+ | Mg2+, Fe3+, Ba2+, Zn2+, EDTA, Fe2+, SDS, NH4+, Al3+, Ca2+ | [ | ||
| 50.7 | 40 | 5 | 18 | Ca2+, Mg2+, Ni2+ | Cu2+, Mn2+ | [ | ||
|
|
| NA | 70 | 5.5 | 360 | NA | NA | [ |
|
| 29.8 | 50 | 6 | NA | Fe3+ | Cu2+ | [ | |
| NA | 42 | 60 | 5.5 | 60.45 | NA | Ca2+, Mn2+, Tween 20/40/60/80 and Trition X-100, DTT and β-ME) | [ |
NA: Not available; EDTA: Ethylenediaminetetraaceticacid; SDS: Sodium Dodecyl Sulfate.
Figure 6Three-dimensional structures of chitosanase: (A) Chitosanase (PDB ID: 1CHK) from streptomyces N174; (B) chitosanase OU01 (PDB ID: 4OLT) of family GH46 from Microbacterium sp.; (C) chitosanase CsnMY002 (PDB ID: 7C6C) from Bacillus subtilis; (D) CBM32 carbohydrate-binding modules (PDB ID: 2RVA) from a Paenibacillus sp. IK-5. β-Strands are shown in cyan-blue and α-helices in magenta. Loops and other secondary structures are in ginger.
Figure 7The reversal mechanism of GH46 chitosanase. Acid/base amino acid group are in cyan-blue ball.